PTPN2 and T-cell acute lymphoblastic leukemia: More generally, TCPTP is thought to serve as a tumor suppressor, particularly in T cell acute lymphoblastic leukemia [45,46], and possibly in breast cancer [47] and liver cancer [48,49].